Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma

NCT01883323 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Metastatic, Stage III or Stage IV, Melanoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Tumor-Infiltrating Lymphocytes
BIOLOGICAL: Low-Dose Interleukin

Sponsor

University Health Network, Toronto